Open AccessNormal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients
Author(s) -
Shi Chen
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i29.3910
Subject(s) - medicine , carcinoembryonic antigen , perioperative , oxaliplatin , chemotherapy , gastroenterology , cancer , gastrectomy , oncology , colorectal cancer , surgery
To evaluate pretreatment serum carcinoembryonic antigen (CEA) as a predictor of survival for patients with locally advanced gastric cancer receiving perioperative chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom